Section of Young Adult Hip Surgery, Division of Sports Medicine, Department of Orthopaedic Surgery, Rush Medical College of Rush University, Rush University Medical Center, Chicago, Illinois, USA.
Am J Sports Med. 2022 Aug;50(10):2598-2605. doi: 10.1177/03635465221107354. Epub 2022 Jul 22.
There is a paucity of information in the literature on midterm outcomes from the arthroscopic treatment of femoroacetabular impingement syndrome (FAIS) with concomitant labral treatment in patients with mild osteoarthritis (OA) using modern surgical techniques.
To compare outcomes of hip arthroscopy for the treatment of FAIS between patients with mild OA (Tönnis grade 1) and patients without OA (Tönnis grade 0) at minimum 5-year follow-up.
Cohort study; Level of evidence, 3.
Patients were identified who underwent primary hip arthroscopy for FAIS with routine capsular closure between January 2012 and December 2015. Patients with Tönnis grade 1 were matched 1:3 by age, sex, and body mass index to patients without OA. The Hip Outcome Score-Activities of Daily Living (HOS-ADL), HOS-Sports Subscale (HOS-SS), modified Harris Hip Score, and 12-item International Hip Outcome Tool were collected preoperatively and at 5 years postoperatively and compared between groups using an independent test. Survivorship rate and percentage achievement of a Patient Acceptable Symptom State (PASS) or minimal clinically important difference (MCID) were compared using a Fisher exact test.
A total of 50 patients (54 hips) with Tönnis grade 1 were matched to 162 patients (162 hips) with Tönnis grade 0. The mean ± SD age and body mass index of the Tönnis grade 1 group were 44.5 ± 9.6 years and 28.5 ± 5.5, respectively. Patient-reported outcome (PRO) scores improved significantly for both groups from presurgery to 5 years postoperatively for all PROs (≤ .03). There were no significant differences in preoperative PROs between the groups. Patients with Tönnis grade 1 had significantly lower postoperative scores on the HOS-ADL (74.7 ± 22.6 vs 83.0 ± 20.1; = .04) and HOS-SS (58.8 ± 33.7 vs 71.8 ± 29.3; = .03) than patients with grade 0. Patients with Tönnis grade 1 also had significantly lower rates of achievement of the MCID (57.1% vs 80.2%; < .01) and PASS (34.1% vs 53.4%; = .03) for any PRO when compared with patients with Tönnis grade 0. Gross survivorship was significantly lower for Tönnis grade 1 versus grade 0 (77.8% vs 96.9%; < .001).
Patients with Tönnis grade 1 arthritis experienced significant improvement in PROs after hip arthroscopy for the treatment of FAIS. However, they had significantly lower postoperative HOS-ADL and HOS-SS scores with significantly lower rates of achievement on the MCID and PASS, with a significantly lower gross survivorship rate at a minimum 5 years postoperatively in comparison with those with Tönnis grade 0 changes.
在使用现代手术技术治疗伴有髋关节盂唇病变的股骨髋臼撞击综合征(FAIS)的关节镜治疗中,关于轻度骨关节炎(OA)患者(Tönnis 分级 1)与无 OA 患者(Tönnis 分级 0)的中期结果的文献资料很少。
比较使用现代手术技术治疗 FAIS 的髋关节镜治疗中,轻度 OA(Tönnis 分级 1)患者与无 OA(Tönnis 分级 0)患者的最低 5 年随访结果。
队列研究;证据等级,3 级。
确定了 2012 年 1 月至 2015 年 12 月期间接受 FAIS 初次髋关节镜治疗的患者。Tönnis 分级 1 患者按年龄、性别和体重指数与无 OA 患者进行 1:3 匹配。术前和术后 5 年收集髋关节结局评分-日常生活活动(HOS-ADL)、髋关节评分-运动亚量表(HOS-SS)、改良 Harris 髋关节评分和 12 项国际髋关节结局工具,并使用独立 t 检验比较两组间的评分。使用 Fisher 确切概率检验比较总体生存率和达到患者可接受症状状态(PASS)或最小临床重要差异(MCID)的百分比。
共 50 例(54 髋)Tönnis 分级 1 患者与 162 例(162 髋)Tönnis 分级 0 患者相匹配。Tönnis 分级 1 组的平均年龄和体重指数分别为 44.5±9.6 岁和 28.5±5.5。两组患者所有 PROs(≤.03)从术前到术后 5 年均显著改善。两组患者术前 PRO 无显著差异。Tönnis 分级 1 患者术后 HOS-ADL(74.7±22.6 比 83.0±20.1; =.04)和 HOS-SS(58.8±33.7 比 71.8±29.3; =.03)评分显著低于 Tönnis 分级 0 患者。Tönnis 分级 1 患者在任何 PRO 中达到 MCID(57.1%比 80.2%; <.01)和 PASS(34.1%比 53.4%; =.03)的比例也显著低于 Tönnis 分级 0 患者。与 Tönnis 分级 0 相比,Tönnis 分级 1 的总生存率显著降低(77.8%比 96.9%; <.001)。
Tönnis 分级 1 关节炎患者在接受髋关节镜治疗 FAIS 后,其 PRO 显著改善。然而,与 Tönnis 分级 0 患者相比,他们的术后 HOS-ADL 和 HOS-SS 评分显著降低,达到 MCID 和 PASS 的比例显著降低,在术后至少 5 年的总体生存率显著降低。